SCHEMBL6581385

SCHEMBL6581385

Cc1ccc2cc(OCc3c(Cl)ccc([N+](=O)[O-])c3Cl)ccc2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HIF1A Q16665 1/20 0.42
S1PR4 O95977 7/20 0.40
MAPT P10636 5/20 0.37
LMNA P02545 2/20 0.37
NPC1 O15118 1/20 0.37
HPGD P15428 1/20 0.37
HTR1A P08908 1/20 0.37
HTR1D P28221 1/20 0.37
HTR1B P28222 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ALDH1A1 P00352 4/20 0.36
MAOB P27338 3/20 0.36
GFER P55789 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6580686 0.89 S1PR4 (0.44) TP53CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6576127 0.89 S1PR4 (0.42) TP53CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6576231 0.87 MAPT (0.40) TP53CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6581453 0.82 ALDH1A1 (0.40) TP53CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6936592 0.81 KDM4E (0.42) CYP1A2CYP2D6MAPTLMNANPC1
SCHEMBL6578371 0.79 ALDH1A1 (0.44) CYP1A2CYP2D6CYP2C9CYP2C19SMN1; SMN2
SCHEMBL6580688 0.79 ALDH1A1 (0.36) TP53CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6578500 0.77 ALDH1A1 (0.43) CYP1A2CYP2D6CYP2C9CYP2C19SMN1; SMN2
SCHEMBL8098950 0.76 S1PR4 (0.37) CYP1A2S1PR4MAPTLMNAALDH1A1
SCHEMBL4600297 0.76 BDKRB2 (0.60) ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0867432-B1 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists AVENTIS PHARMA GMBH (DE) 2004-06-09 EP disclosed
EP-0796848-B1 Fluoralkyl- and fluoralkoxy-substituted heterocyclic bradykinin antagonists HOECHST AG (DE) 2003-06-04 EP disclosed
EP-0867432-A2 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists HOECHST AKTIENGESELLSCHAFT (DE) 1998-09-30 EP disclosed
EP-0796848-A1 Fluoralkyl- and fluoralkoxy-substituted heterocyclic bradykinin antagonists HOECHST AKTIENGESELLSCHAFT (DE) 1997-09-24 EP disclosed